维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Yonal"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI) : Usefulness in patients with chronic liver disease: APRI in chronic liver disease 显示文摘	Yilmaz Y Yonal O Kurt R	2011	Hepat Mon2011，11，2：	1
2	Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Eren F Yonal O	2011	Dis Markers2011，31，4：	1
3	Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yusuf Yilmaz Oya Yonal Ramazan Kurt Yesim Ozen Alahdab Fatih Eren Osman Ozdogan Cigdem Ataizi Celikel Nese Imeryuz Cem Kalayci Erol Avsar	2011	Scandinavian Journal of Gastroenterology2011，，1：	1
4	Serum levels of omen-tin,chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Yonal O Kurt R	2011	Scand J Gastroen-terol2011，46，1：	1
5	Dipeptidyl peptidase IV inhibi- tors: therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O etal	2009	Med Sci Monit2009，15，4：	1
6	Decreased prohepcidin levels in patients with HBV-related liver disease:relation with ferritin levels显示文摘	Yonal O Akyuz F Demir K	2010	Dig Dis Sci2010，55，12：	1
7	The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving che moradiot he rapy显示文摘	Atasoy BM Yonal O Demirel B	2012	Eur Arch Otorhinolaryngol2012，269，1：	1
8	Primary Ma- lignant Melanoma of the Esophagus显示文摘	Oya Yonal Duygu Ibrisim Y1 ldl ran Songur	2013	Case Rep Gastroenterol2013，7，：	1
9	Dipeptidyl peptidase IV in- hibitors :therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O	2009	Med Sci Monit2009，15，4：	1
10	Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease显示文摘	Yilmaz Y Eren F Yonal O	2010	Eur J Clin Invest2010，40，10：	1
11	Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fattyliver dis- ease显示文摘	YILMAZ Y ATUG O YONAL O	2009	Med SciMonit2009，15，4：	1
12	Dipeptidyl peptidase Ⅳ inhibitors: therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O	2009	Med Sci Monit2009，15，4：	1
13	Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Yonal O Kurt R	2011	Scand J Gastroenterol2011，46，1：	1
14	Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease:association with liver fibrosis显示文摘	Yilmaz Y Alahdab YO Yonal O		0，，09：	1
15	Serum progranulin as an independent market of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmas Y Eren F Yonal O	2011	Dis Markers2011，31，4：	1
16	Serum fetuin A/2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis显示文摘	Yilmaz Y Yonal O Kurt R	2010	Ann Clin Biochem2010，47，6：	1
17	Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity显示文摘	Y. Yilmaz O. Yonal F. Eren O. Atug H. Over Hamzaoglu	2011	Journal of Crohn’s and Colitis2011，，5：	1
18	Microalbuminuria in nondiabetic patients withnonalcoholic fatty liver disease : association withliver fibrosis 显示文摘	YILMAZ Y ALAHDAB Y O YONAL O	2010	Metabolism2010，59，：	1
19	Electronic dictionaries in the classroom!? Bah,Humbug!显示文摘	Yonally D S.Gilbert		0，，01：	1
20	Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Yonal O Kurt R	2010	Scand J Gastroenterol2010，46，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示